SAN DIEGO, March 14 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) today announced that Ken Buechler, Ph.D., Biosite's president
and chief scientific officer, will discuss the Company's current operating
environment, business strategy, clinical programs and new data from
MultiMarker Index research pertaining to the evaluation of chest pain at the
SG Cowen & Co. 25th Annual Health Care Conference. Biosite's presentation
will take place Wednesday, March 16, 2005, at 8:00 a.m. Eastern. The
conference is to be held at the Marriott Copley Place Hotel in Boston, Mass.
A link to the live audio webcast and presentation can be accessed through
the Biosite website, http://www.biosite.com. The Biosite presentation will be
archived on the website for 21 days in the Investor and Media section under
Events Calendar.
A leader in the drive to advance diagnosis, Biosite Incorporated is a
research-based company dedicated to the discovery and development of novel
protein-based diagnostics that improve a physician's ability to diagnose
debilitating and life-threatening diseases. Biosite's Triage(R) rapid
diagnostics are used in approximately 50 percent of U.S. hospitals and in more
than 50 international markets for toxicology screening and diagnosis of
infectious and cardiovascular disease. Information on Biosite can be found at
http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations of Biosite Incorporated, +1-858-455-4808, ext.
3187, npadilla@biosite.com
|
